BACE1 gene regulation: A novel drug target in Alzheimer's disease

and perspective provided by an experienced researcher and investigator involved in a recently completed disease modifying immunotherapy program. Conclusions: It is imperative that methodological issues be identified and appropriately addressed in order to enhance the probability of success as the field moves forward into the long term investigation of earlier therapeutic interventions. We cannot afford to repeat the mistakes of the past.